Objective: This study aims to explore the correlation between human papillomavirus (HPV) and Mycoplasma genitalium (CT) combined with TCT detection in cervical cancer screening. Method: A cross-sectional study design was adopted, and a total of 609 women who came to seek medical treatment were recruited as the study subjects. Combination testing was evaluated on cervical cancer screening by testing the women for HPV, CT with TCT detection and analyzing the relationship of cervical lesions with HPV and CT infection. Results: The study results showed that 21.57% of the subjects were infected with both HPV and CT, and 48.42% of the cases had abnormal TCT results at the same time. Further data analysis showed that HPV infection was significantly associated with abnormal TCT outcomes (p < 0.05), suggesting a possible synergistic effect of the two infections in cervical lesions. The combined sensitivity and specificity of HPV, CT and TCT detection were 21.57% and 48.42%, respectively, which were significantly higher than that of single detection. Conclusion: In summary, the results of this study support the importance of combined HPV, CT, and TCT testing in cervical cancer screening, and propose the hypothesis that combined testing may improve screening effectiveness. However, further large sample studies are needed to confirm this conclusion and explore the prospects of combined testing in clinical practice.
References
[1]
Huang, X.L. (2024) Effects of Vaginal Chlamydia Trachomatis and Mycoplasma Genital Tract on Sex Hormones and Inflammatory Factors in Female Infertility Patients. Chinese and Foreign Medical Research, 22, 79-82.
[2]
Ye, Y. and Shan, L.Y. (2024) The Value of Liquid Based Thin-Layer Cell Detection Combined with High-Risk Human Papillomavirus Detection in the Diagnosis of Cervical Precancerous Lesions. Journal of Maternal and Child Health, 3, 104-107.
[3]
Shi, Q.B. and Yuan, F.L. (2024) The Application Value of TCT Combined with HPV in Cervical Cancer Screening and Its Relationship with Vaginal Infection. Chinese Journal of Family Planning, 32, 1158-1161.
[4]
Yang, X.Q., Yao, F. and Yang, Z.F. (2024) Observation of Diagnostic Efficacy of High-Risk Human Papillomavirus Combined with Thin-Layer Liquid Based Cytology in Patients with Cervical Cancer and Precancerous Lesions. Guizhou Medical Journal, 48, 204-205.
[5]
Xu, Y.R., Lin, J.T., Zhou, Z.W., et al. (2022) The Relationship between CT, NG, and HPV Infection and Their Correlation with Cervical Lesions. Journal of Molecular Diagnosis and Treatment, 14, 2215-2218.
[6]
Hua, L.Z., Xiao, M., Yin, X.Y., et al. (2023) Vaginal Microbiota Changes in High-Risk HPV Infection Patients with Advanced Cervical Intraepithelial Neoplasia. Chinese Journal of Obstetrics and Gynecology, 24, 467-469.
[7]
Liu, H., Zhao, H. and Li, Y. (2024) The Correlation between Vaginal Microbiota and Human Papillomavirus Infection and Cervical Lesions. Chinese Journal of Practical Diagnosis and Treatment, 38, 195-200.
[8]
Zhang, L.G., Liu, Y.L. and Dong, T. (2024) Correlation Analysis of Human Papillomavirus Infection, Vaginal Microenvironment Indicators, and Cervical Leions. Journal of Laboratory Medicine and Clinical Medicine, 21, 199-202.
[9]
Xu, F.Q. (2023) The Impact of Female Reproductive Tract Infections with Mycoplasma Urealyticum and Chlamydia Trachomatis on Spontaneous Abortion. Journal of Maternal and Child Health, 2, 107-109.
[10]
Wang, Y., Xiang, X., Chen, J.L., et al. (2023) Study on the Influence of Vaginal Microbiota on High-Risk Human Papillomavirus Infection in the Cervix. Anhui Medical Journal, 44, 234-237.
[11]
Wei, B.Y. and Zhou, X. (2024) Correlation Analysis between Female Reproductive Tract Mycoplasma and Chlamydia Infections and HPV Infection. Chinese Journal of Practical Rural Doctors, 31, 42-46.
[12]
Chen, H.C., Xie, P.L., Fang, B.X., et al. (2023) Analysis of the Relationship between High-Risk Human Papillomavirus Infection and Mycoplasma Infection in the Urogenital Tract. Journal of Laboratory Medicine and Clinical Medicine, 20, 3589-3593.
[13]
Yang, L.L. and Li, M. (2023) Relationship between Mycoplasma and Chlamydia Infection in Reproductive Tract and Human Papillomavirus Infection in Reproductive Age Women. Chinese Journal of Family Planning, 31, 1176-1180.
[14]
Xue, T., Chen, K.S., Wei, N., et al. (2023) The Diagnostic Value of TCT Combined with p16/Ki-67 Double Staining and HPV E6/E7 mRNA Detection in Cervical Squamous Intraepithelial Lesions. Journal of Zhengzhou University (Medical Edition), 58, 391-394.
[15]
Liu, D.B., Chen, W.W. and Wu, S.G. (2022) Correlation Analysis of Human Papillomavirus Infection with Mycoplasma Urogenital Tract Infection and Drug Resistance Rate. Modern Medicine and Health, 38, 3639-3642.
[16]
Huang, L., Liu, L.W. and Ling, Y.Z. (2022) Analysis of the Relationship between Common Vaginal Microbial Infections and Cervical Human Papillomavirus Infection. Chinese Community Physician, 38, 56-58.
[17]
Men, J.N., Wang, Z., Wang, D.N., et al. (2023) Research Progress on the Correlation between High-Risk Human Papillomavirus and Vaginal Microbiota. Journal of Difficult Diseases, 22, 1332-1335.
[18]
Zhao, W.X., Mao, C.Y., Zhu, X.Y., et al. (2014) The Clinical Significance of the Combination of HPV and TCT as the Initial Screening for Cervical Cancer. Chinese Journal of Maternal and Child Health, 29, 187-189.
[19]
Li, X.H. and Zhang, Q. (2024) Analysis of the Characteristics of Human Papillomavirus Infection in 10818 Healthy Women Undergoing Physical Examinations in Dalian Area. Labeled Immunoassay and Clinical, 31, 303-307.
[20]
Deng, L., Lin, L. and Zhang, C.C. (2023) Analysis of Mycoplasma Culture and Drug Sensitivity Test Results in Cervical Secretions of Women of Childbearing Age. Journal of Practical Laboratory Physicians, 15, 401-404.
